• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫性血小板减少症揭示IgG-4丰富的肾周罗萨伊-多夫曼病,利妥昔单抗成功治疗:一例报告及文献综述

Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.

作者信息

Razanamahery Jerome, Humbert Sebastien, Emile Jean-Francois, Cohen-Aubart Fleur, Fontan Jean, Maksud Philippe, Audia Sylvain, Haroche Julien

机构信息

Internal Medicine Department and Clinical Immunology, Dijon University Hospital, Dijon, France.

Internal Medicine Department, Besancon University Hospital, Besançon, France.

出版信息

Front Med (Lausanne). 2021 Jun 16;8:678456. doi: 10.3389/fmed.2021.678456. eCollection 2021.

DOI:10.3389/fmed.2021.678456
PMID:34222286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8244783/
Abstract

Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (<100 G/L) after exclusion of other causes. Mostly primary, it is associated with hematological malignancy, autoimmune disorders, or infection in 20% of patients. It is exceptionally described in patients with histiocytosis, mostly in children (seven patients in literature). We report a case of a 69-year-old man with ITP leading to the diagnosis of histiocytosis. At ITP's diagnosis, the patient had elevated gamma-globulins leading to computed tomography showing bilateral peri-renal infiltration. The biopsy showed enriched IgG-4 peri-renal Rosai Dorfman disease with mutation, although peri-renal infiltration is highly suggestive of Erdheim-Chester disease. This overlapping association was described in men with mutation in gene. Macrophages are implicated in the pathophysiology of ITP in multiple ways, notably by the phagocytosis of opsonized platelets and their function of antigen-presenting cells able to stimulate autoreactive T cells. Histiocytic cells derivate from monocyte-macrophage lineage. Activation of macrophages in active histiocytosis is responsible for consequential platelet destruction in ITP associated histiocytosis. Finally, this case highlights a rare presentation of ITP revealing histiocytosis, both being efficiently treated with rituximab.

摘要

免疫性血小板减少症(ITP)是一种罕见的自身免疫介导性疾病,其特征为排除其他病因后出现孤立性血小板减少(<100 G/L)。多数为原发性,20%的患者与血液系统恶性肿瘤、自身免疫性疾病或感染有关。在组织细胞增多症患者中也有罕见报道,主要见于儿童(文献中有7例患者)。我们报告一例69岁男性ITP患者,最终诊断为组织细胞增多症。在诊断ITP时,患者γ球蛋白升高,计算机断层扫描显示双侧肾周浸润。活检显示富含IgG-4的肾周罗萨伊-多夫曼病伴 突变,尽管肾周浸润高度提示厄尔德海姆-切斯特病。这种重叠关联在有 基因突变的男性中已有描述。巨噬细胞以多种方式参与ITP的病理生理过程,特别是通过吞噬调理素化的血小板及其作为能够刺激自身反应性T细胞的抗原呈递细胞的功能。组织细胞来源于单核细胞-巨噬细胞谱系。活动性组织细胞增多症中巨噬细胞的激活是ITP相关组织细胞增多症中血小板破坏的原因。最后,该病例突出了ITP罕见的表现形式,揭示了组织细胞增多症,两者均可用利妥昔单抗有效治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/a0f078c638ff/fmed-08-678456-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/0d85d5fa7d53/fmed-08-678456-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/a0f078c638ff/fmed-08-678456-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/0d85d5fa7d53/fmed-08-678456-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/517b/8244783/a0f078c638ff/fmed-08-678456-g0002.jpg

相似文献

1
Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.免疫性血小板减少症揭示IgG-4丰富的肾周罗萨伊-多夫曼病,利妥昔单抗成功治疗:一例报告及文献综述
Front Med (Lausanne). 2021 Jun 16;8:678456. doi: 10.3389/fmed.2021.678456. eCollection 2021.
2
MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.MAP2K1 驱动的朗格汉斯细胞组织细胞增生症、罗道尔夫-多布姆病和埃勒-当斯伯格病与急性髓系白血病克隆相关。
J Cutan Pathol. 2021 May;48(5):637-643. doi: 10.1111/cup.13918. Epub 2020 Nov 24.
3
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.成人组织细胞增生症的治疗要点:朗格汉斯细胞组织细胞增生症、 Erdheim-Chester 病、Rosai-Dorfman 病和噬血细胞性淋巴组织细胞增生症。
Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e66-e75. doi: 10.1016/j.clml.2020.08.007. Epub 2020 Aug 18.
4
Symptomatic Rosai-Dorfman Disease Presenting as Isolated Bilateral Perinephric Infiltration.表现为孤立性双侧肾周浸润的症状性罗萨伊-多夫曼病
Rev Urol. 2019;21(1):41-44.
5
Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.肺组织细胞增多症:超越与吸烟相关的朗格汉斯细胞组织细胞增多症
Radiologia (Engl Ed). 2019 May-Jun;61(3):215-224. doi: 10.1016/j.rx.2018.11.003. Epub 2019 Jan 24.
6
How I Diagnose Rosai-Dorfman Disease.我如何诊断罗斯-道尔夫曼病。
Am J Clin Pathol. 2023 Jul 5;160(1):1-10. doi: 10.1093/ajcp/aqad047.
7
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.厄德海姆-切斯特病伴罗萨达-多夫曼样病变:甲氨蝶呤、阿那白滞素和乌帕替尼治疗。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002852.
8
Histiocytosis.组织细胞增多症
Med Clin (Barc). 2023 Aug 25;161(4):166-175. doi: 10.1016/j.medcli.2023.05.001. Epub 2023 May 30.
9
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.罗道尔夫病中相互排斥的 KRAS 和 MAP2K1 突变。
Mod Pathol. 2017 Oct;30(10):1367-1377. doi: 10.1038/modpathol.2017.55. Epub 2017 Jun 30.
10
[Histiocytic diseases in childhood and adolescence].[儿童及青少年组织细胞疾病]
Pathologe. 2015 Sep;36(5):443-50. doi: 10.1007/s00292-015-0043-x.

引用本文的文献

1
Asymptomatic Rosai-Dorfman-Destombes disease presenting as isolated bilateral perinephric infiltration: a case report and review of the literature.表现为孤立性双侧肾周浸润的无症状性罗萨伊-多夫曼-德斯顿贝斯病:一例报告并文献复习
Transl Androl Urol. 2023 Feb 28;12(2):347-352. doi: 10.21037/tau-22-742. Epub 2023 Feb 9.

本文引用的文献

1
Management of IgG4-related disease.IgG4相关性疾病的管理
Lancet Rheumatol. 2019 Sep;1(1):e55-e65. doi: 10.1016/S2665-9913(19)30017-7. Epub 2019 Aug 28.
2
Histiocytosis.组织细胞增生症。
Lancet. 2021 Jul 10;398(10295):157-170. doi: 10.1016/S0140-6736(21)00311-1. Epub 2021 Apr 23.
3
High frequency of clonal hematopoiesis in Erdheim-Chester disease.高频克隆性造血见于 Erdheim-Chester 病。
Blood. 2021 Jan 28;137(4):485-492. doi: 10.1182/blood.2020005101.
4
Bone Marrow Langerhans Cell Histiocytosis in Association with Kasabach-Merritt Syndrome: The Difficulty of a Differential Diagnosis.骨髓朗格汉斯细胞组织细胞增多症合并卡萨巴赫-梅里特综合征:鉴别诊断的难点
Case Rep Oncol. 2020 Apr 14;13(1):408-413. doi: 10.1159/000506539. eCollection 2020 Jan-Apr.
5
Erdheim-Chester disease.额颞叶痴呆。
Blood. 2020 Apr 16;135(16):1311-1318. doi: 10.1182/blood.2019002766.
6
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia.脾脏巨噬细胞上的FcγRI和FcγRIII介导免疫性血小板减少症中抗糖蛋白IIb/IIIa自身抗体调理血小板的吞噬作用。
Haematologica. 2021 Jan 1;106(1):250-254. doi: 10.3324/haematol.2020.248385.
7
Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症。
Blood. 2020 Apr 16;135(16):1319-1331. doi: 10.1182/blood.2019000934.
8
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
9
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.利妥昔单抗治疗 248 例成人免疫性血小板减少症的长期安全性和有效性:来自法国前瞻性登记研究 ITP-ritux 的 5 年结果。
Am J Hematol. 2019 Dec;94(12):1314-1324. doi: 10.1002/ajh.25632. Epub 2019 Oct 8.
10
Autoimmune Diseases and Rosai-Dorfman Disease Coexist More Commonly than Expected: Two Case Reports.自身免疫性疾病与罗萨伊-多夫曼病共存的情况比预期更常见:两例病例报告。
Am J Case Rep. 2019 May 31;20:770-772. doi: 10.12659/AJCR.915627.